Feeds:
Posts
Comments

Posts Tagged ‘Vars’

The Centers for Disease Control(CDC) believes that up to 12 million fewer doses of H1N1 vaccine than expected will be available by month’s end. Availability will be limited for the next week or two due to manufacturing delays. The CDC had hoped 40 million doses would be available by end of October, but this is very unlikely. http://www.huliq.com/8059/87759/h1n1-swine-flu-production-slower-expected

2009 H1N1 Influenza Vaccine Supply Status

Aggregate Totals
Posted October 16, 2009, 12:00 PM ET
Doses Allocated as of 10/14/09* 11,422,900
Doses Ordered as of 10/14/09 7,971,800
Doses Shipped as of 10/14/09** 5,885,900
*Doses allocated to project areas for ordering are those that are at the distribution depots and ready for project areas to order.
Vaccine is allocated to each project area in proportion to its population (pro rata).

**There is a lag time between allocation, ordering, and shipment of doses as project areas place orders and those orders are processed and shipped.

Project areas reflect CDC Public Health Emergency Response (PHER) Grantees.

http://www.cdc.gov/h1n1flu/vaccination/vaccinesupply.htm

Dr. Anne Schuchat, CDC’s director of the National Center for Immunization and Respiratory Diseases reported on Friday that manufacturers are making unprecedented amounts of vaccine, but difficulties growing the vaccine, as well as time-consuming potency and purity testing, are contributing to the delay. “We are not cutting any corners in the safety of the production of the vaccine or the testing and oversight of the vaccine” Schuchat explained.

Let us explain. The 2009 H1N1 Vaccine should be labeled as toxic waste.  Here are the patient inserts on each of the approved vaccines in the U.S. https://ahrcanum.wordpress.com/2009/09/27/h1n1-swine-flu-vaccine-package-insert-warnings/  All were given fast track approval based on how previous seasonal vaccines were manufactured.  All have legal immunity from any lawsuits that might arise due to injury.  Quite simply, the CDC has cut corners.

 

flag tounge

Open wide, say ahhh and check out these posts on the A/H1N1 Swine Flu from Ahrcanum, where the conspiracy spreads as fast as the virus itself.

Opinions are like a$$holes, everyone has one.  SUBSCRIBE NOW to our opinions in the top right margin for updates.

https://ahrcanum.wordpress.com/swine-flu-report/

Read Full Post »

The U.S. Government has evaluated only these vaccines that are licensed by the U.S. Food and Drug Administration. They are-

Influenza A (H1N1) 2009 Monovalent Vaccine (CSL Limited)http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181975.htm

Influenza A (H1N1) 2009 Monovalent Vaccine (Novartis Vaccines and Diagnostics Limited) http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181973.htm

Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur, Inc)  http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181971.htm

Influenza A (H1N1) 2009 Monovalent Vaccine (MedImmune LLC) http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181970.htm

Lot release information will be updated weekly.  Last update: 9/24/2009.  http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm181956.htm

Manufacturer Total Number of Lots Released by FDA
MedImmune LLC 9
Novartis Vaccines and Diagnostics Limited 3
Sanofi Pasteur, Inc. 3

From the CSL package insert: Influenza A (H1N1) 2009 Monovalent Vaccine,  Manufactured by CSL Limited, Suspension for Intramuscular Injection, Initial U.S. Approval: 2007 [sic- approved TWO YEARS AGO!)

From the CSL package insert

Vaccination with Influenza A (H1N1) 2009 Monovalent Vaccine may not protect all individuals.

5.4 Limitations of Vaccine Effectiveness

Neurological disorders temporally associated with influenza vaccination, such as encephalopathy, optic neuritis/neuropathy, partial facial paralysis, and brachial plexus neuropathy, have been reported.

8.1 Pregnancy

Pregnancy Category C: Animal reproduction studies have not been conducted with Influenza A (H1N1) 2009 Monovalent Vaccine or AFLURIA. It is also not known whether these vaccines can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Influenza A (H1N1) 2009 Monovalent Vaccine should be given to a pregnant woman only if clearly needed.

8.3 Nursing Mothers

Neither Influenza A (H1N1) 2009 Monovalent Vaccine nor AFLURIA has been evaluated in nursing mothers. It is not known whether Influenza A (H1N1) 2009 Monovalent Vaccine or AFLURIA is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Influenza A (H1N1) 2009 Monovalent Vaccine is administered to a nursing woman.

8.4 Pediatric Use

   Neither Influenza A (H1N1) 2009 Monovalent Vaccine nor AFLURIA has been evaluated in children. Safety and effectiveness in the pediatric population have not been established.

Similar warnings from the Novartis inserthttp://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM182242.pdf

 8.3 Nursing Mothers-It is not known whether FLUVIRIN or Influenza A (H1N1) 2009 Monovalent Vaccine is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Influenza A (H1N1) 2009 Monovalent Vaccine is administered to a nursing woman

 

 8.4 Pediatric UseSafety and effectiveness in pediatric subjects below the age of 4 years have not been established. [see ADVERSE REACTIONS (6) and CLINICAL STUDIES (14)] 

Pregnancy Category C: Animal reproduction studies have not been conducted with Influenza A (H1N1) 2009 Monovalent Vaccine or FLUVIRIN. It is also not known whether Influenza A (H1N1) 2009 Monovalent Vaccine or FLUVIRIN can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Influenza A (H1N1) 2009 Monovalent Vaccine should be given to a pregnant woman only if clearly needed.

The government is starting an unprecedented system to track possible side effects as mass flu vaccinations begin next month. The idea is to detect any rare but real problems quickly, and explain the inevitable coincidences that are sure to cause some false alarms.

“Every day, bad things happen to people. When you vaccinate a lot of people in a short period of time, some of those things are going to happen to some people by chance alone,” said Dr. Daniel Salmon, a vaccine safety specialist at the Department of Health and Human Services. http://www.philly.com/philly/wires/ap/features/health/20090927_ap_swineflushotintensetrackingforsideeffects.html

Just how did CSL Limited, Suspension for Intramuscular Injection get Initial U.S. Approval in 2007?????? TWO YEARS before the explosion of H1N1 around the world.  These patient inserts appear to be from the respective manufacturers of the seasonal flu vaccine, only adding the text for H1N1 with no large clinical studies.

US officials say the first swine flu vaccine will be available on Oct. 5. http://www.presstv.ir/detail.aspx?id=107252&sectionid=3510210  Women and children first please. 

Do not sign on the dotted line. 

 flag tounge

Open wide, say ahhh and check out these posts on the A/H1N1 Swine Flu from Ahrcanum, where the conspiracy spreads as fast as the virus itself.

Swine Flu Conspiracy can sometimes be triggered by real world events.  Subscribe NOW in the top right margin for further updates.

https://ahrcanum.wordpress.com/swine-flu-report/

 

Read Full Post »